Table 2.
Correlation of the virus reservoir with CyTOF markers´ expression on CD8 + and CD4 + T cells isolated from patients starting ART at the acute and chronic phase of infection.
| Marker | CD8 + T cells | CD4 + T cells | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EA | LA | All patients | EA | LA | All patients | |||||||
| rho | p | rho | p | rho | p | rho | p | rho | p | rho | p | |
| CCR4 | − 0.685 | 0.035 | − 0.224 | 0.537 | − 0.552 | 0.013 | − 0.261 | 0.470 | − 0.273 | 0.448 | − 0.359 | 0.120 |
| CCR5 | 0.018 | 0.973 | − 0.467 | 0.178 | − 0.474 | 0.036 | − 0.055 | 0.892 | − 0.333 | 0.349 | − 0.430 | 0.060 |
| CCR6 | 0.067 | 0.865 | 0.285 | 0.427 | − 0.367 | 0.112 | − 0.236 | 0.514 | 0.321 | 0.368 | − 0.123 | 0.603 |
| CD127 | − 0.321 | 0.368 | − 0.564 | 0.096 | − 0.504 | 0.025 | 0.042 | 0.919 | 0.018 | 0.973 | − 0.165 | 0.484 |
| CD161 | − 0.285 | 0.427 | 0.527 | 0.123 | − 0.132 | 0.577 | − 0.467 | 0.178 | 0.309 | 0.387 | − 0.101 | 0.672 |
| CD27 | − 0.418 | 0.232 | − 0.673 | 0.039 | − 0.507 | 0.024 | − 0.636 | 0.054 | − 0.248 | 0.492 | − 0.340 | 0.143 |
| CD28 | − 0.418 | 0.232 | − 0.648 | 0.049 | − 0.484 | 0.032 | − 0.515 | 0.133 | − 0.139 | 0.707 | − 0.377 | 0.102 |
| CD31 | − 0.055 | 0.892 | − 0.152 | 0.682 | − 0.242 | 0.302 | − 0.103 | 0.785 | 0.127 | 0.733 | − 0.095 | 0.691 |
| CD38 | 0.103 | 0.785 | 0.079 | 0.838 | 0.011 | 0.967 | − 0.248 | 0.492 | − 0.006 | 1.000 | 0.146 | 0.538 |
| CD39 | 0.479 | 0.166 | 0.564 | 0.096 | 0.128 | 0.590 | 0.539 | 0.113 | 0.273 | 0.448 | − 0.003 | 0.992 |
| CD4 | − 0.624 | 0.060 | 0.091 | 0.811 | − 0.544 | 0.014 | NA | NA | NA | NA | NA | NA |
| CD3 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| CD44 | 0.333 | 0.349 | 0.794 | 0.010 | 0.245 | 0.296 | 0.176 | 0.632 | − 0.345 | 0.331 | 0.152 | 0.521 |
| CD45 | 0.576 | 0.088 | 0.127 | 0.733 | 0.568 | 0.010 | − 0.224 | 0.537 | 0.248 | 0.492 | 0.504 | 0.025 |
| CD45RA | − 0.406 | 0.247 | 0.539 | 0.113 | 0.030 | 0.901 | 0.515 | 0.133 | − 0.152 | 0.682 | − 0.140 | 0.555 |
| CD5 | 0.564 | 0.096 | − 0.321 | 0.368 | 0.164 | 0.488 | 0.370 | 0.296 | 0.321 | 0.368 | 0.155 | 0.513 |
| CD57 | 0.382 | 0.279 | 0.576 | 0.088 | 0.436 | 0.056 | − 0.406 | 0.247 | 0.030 | 0.946 | 0.420 | 0.067 |
| CD8 | NA | NA | NA | NA | NA | NA | − 0.176 | 0.632 | 0.067 | 0.865 | − 0.105 | 0.658 |
| CTLA-4 | − 0.745 | 0.018 | − 0.297 | 0.407 | − 0.644 | 0.003 | − 0.600 | 0.073 | − 0.091 | 0.811 | − 0.368 | 0.111 |
| CXCR3 | 0.406 | 0.247 | 0.455 | 0.191 | 0.275 | 0.239 | 0.503 | 0.143 | 0.333 | 0.349 | 0.395 | 0.085 |
| CXCR5 | − 0.176 | 0.632 | − 0.067 | 0.865 | − 0.469 | 0.038 | − 0.527 | 0.123 | − 0.067 | 0.865 | − 0.454 | 0.046 |
| HLA-DR | 0.358 | 0.313 | − 0.188 | 0.608 | 0.005 | 0.987 | 0.152 | 0.682 | − 0.624 | 0.060 | − 0.020 | 0.937 |
| ICOS | − 0.248 | 0.492 | 0.103 | 0.785 | − 0.233 | 0.321 | 0.018 | 0.973 | − 0.152 | 0.682 | − 0.095 | 0.691 |
| Ki-67 | − 0.006 | 1.000 | 0.152 | 0.682 | 0.250 | 0.287 | − 0.539 | 0.113 | 0.164 | 0.657 | − 0.268 | 0.253 |
| PD-1 | − 0.152 | 0.682 | 0.091 | 0.811 | 0.002 | 0.997 | 0.212 | 0.560 | 0.103 | 0.785 | − 0.084 | 0.724 |
| TCRab | − 0.442 | 0.204 | 0.236 | 0.514 | − 0.101 | 0.672 | − 0.030 | 0.946 | − 0.042 | 0.919 | − 0.030 | 0.901 |
Non T cell-specific markers, CD19 and CD11c, were excluded.
EA early ART at acute infection, LA late ART at chronic infection, NA not applicable.